The global PSMA Antibody market size was valued at US$ 507 million in 2024 and is forecast to a readjusted size of USD 1120 million by 2031 with a CAGR of 12.1% during review period.
PSMA Antibody, also known as Prostate-Specific Membrane Antigen antibody, is a specific antibody used to detect and study PSMA protein (Prostate-Specific Membrane Antigen).
PSMA is a membrane surface antigen that is highly expressed mainly in prostate tissue and is therefore often used as a marker for prostate cancer. In addition to its expression in prostate tissue, PSMA is also expressed at low levels in other tissues and tumors. Due to its important role in the diagnosis, staging and treatment of prostate cancer, PSMA antibodies have important application value in cancer diagnosis and research. PSMA antibody can be used to study the expression distribution of PSMA, diagnose prostate cancer, explore anti-tumor treatment strategies, etc., and help to understand the function and clinical application potential of PSMA in tumor biology.
This report is a detailed and comprehensive analysis for global PSMA Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global PSMA Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global PSMA Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global PSMA Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global PSMA Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PSMA Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PSMA Antibody market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sino Biological, Inc., ACROBiosystems, Bio-Techne, Abcam, Elabscience Biotechnology Inc., LifeSpan BioSciences, Inc, ProSci Incorporated, Boster Biological Technology, Abbexa, Assay Genie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
PSMA Antibody market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Monoclonal Antibody
Polyclonal Antibody
麻豆原创 segment by Application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
Major players covered
Sino Biological, Inc.
ACROBiosystems
Bio-Techne
Abcam
Elabscience Biotechnology Inc.
LifeSpan BioSciences, Inc
ProSci Incorporated
Boster Biological Technology
Abbexa
Assay Genie
Innovative Research
G&P Biosciences
Arigo Biolaboratories Corp.
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PSMA Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PSMA Antibody, with price, sales quantity, revenue, and global market share of PSMA Antibody from 2020 to 2025.
Chapter 3, the PSMA Antibody competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PSMA Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and PSMA Antibody market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PSMA Antibody.
Chapter 14 and 15, to describe PSMA Antibody sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global PSMA Antibody Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Monoclonal Antibody
1.3.3 Polyclonal Antibody
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global PSMA Antibody Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Flow Cytometry
1.4.3 ELISA
1.4.4 Western Blot
1.4.5 Immunoprecipitation
1.4.6 Immunofluorescence
1.4.7 Others
1.5 Global PSMA Antibody 麻豆原创 Size & Forecast
1.5.1 Global PSMA Antibody Consumption Value (2020 & 2024 & 2031)
1.5.2 Global PSMA Antibody Sales Quantity (2020-2031)
1.5.3 Global PSMA Antibody Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Sino Biological, Inc.
2.1.1 Sino Biological, Inc. Details
2.1.2 Sino Biological, Inc. Major Business
2.1.3 Sino Biological, Inc. PSMA Antibody Product and Services
2.1.4 Sino Biological, Inc. PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Sino Biological, Inc. Recent Developments/Updates
2.2 ACROBiosystems
2.2.1 ACROBiosystems Details
2.2.2 ACROBiosystems Major Business
2.2.3 ACROBiosystems PSMA Antibody Product and Services
2.2.4 ACROBiosystems PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 ACROBiosystems Recent Developments/Updates
2.3 Bio-Techne
2.3.1 Bio-Techne Details
2.3.2 Bio-Techne Major Business
2.3.3 Bio-Techne PSMA Antibody Product and Services
2.3.4 Bio-Techne PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Bio-Techne Recent Developments/Updates
2.4 Abcam
2.4.1 Abcam Details
2.4.2 Abcam Major Business
2.4.3 Abcam PSMA Antibody Product and Services
2.4.4 Abcam PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Abcam Recent Developments/Updates
2.5 Elabscience Biotechnology Inc.
2.5.1 Elabscience Biotechnology Inc. Details
2.5.2 Elabscience Biotechnology Inc. Major Business
2.5.3 Elabscience Biotechnology Inc. PSMA Antibody Product and Services
2.5.4 Elabscience Biotechnology Inc. PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Elabscience Biotechnology Inc. Recent Developments/Updates
2.6 LifeSpan BioSciences, Inc
2.6.1 LifeSpan BioSciences, Inc Details
2.6.2 LifeSpan BioSciences, Inc Major Business
2.6.3 LifeSpan BioSciences, Inc PSMA Antibody Product and Services
2.6.4 LifeSpan BioSciences, Inc PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 LifeSpan BioSciences, Inc Recent Developments/Updates
2.7 ProSci Incorporated
2.7.1 ProSci Incorporated Details
2.7.2 ProSci Incorporated Major Business
2.7.3 ProSci Incorporated PSMA Antibody Product and Services
2.7.4 ProSci Incorporated PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 ProSci Incorporated Recent Developments/Updates
2.8 Boster Biological Technology
2.8.1 Boster Biological Technology Details
2.8.2 Boster Biological Technology Major Business
2.8.3 Boster Biological Technology PSMA Antibody Product and Services
2.8.4 Boster Biological Technology PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Boster Biological Technology Recent Developments/Updates
2.9 Abbexa
2.9.1 Abbexa Details
2.9.2 Abbexa Major Business
2.9.3 Abbexa PSMA Antibody Product and Services
2.9.4 Abbexa PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Abbexa Recent Developments/Updates
2.10 Assay Genie
2.10.1 Assay Genie Details
2.10.2 Assay Genie Major Business
2.10.3 Assay Genie PSMA Antibody Product and Services
2.10.4 Assay Genie PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Assay Genie Recent Developments/Updates
2.11 Innovative Research
2.11.1 Innovative Research Details
2.11.2 Innovative Research Major Business
2.11.3 Innovative Research PSMA Antibody Product and Services
2.11.4 Innovative Research PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Innovative Research Recent Developments/Updates
2.12 G&P Biosciences
2.12.1 G&P Biosciences Details
2.12.2 G&P Biosciences Major Business
2.12.3 G&P Biosciences PSMA Antibody Product and Services
2.12.4 G&P Biosciences PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 G&P Biosciences Recent Developments/Updates
2.13 Arigo Biolaboratories Corp.
2.13.1 Arigo Biolaboratories Corp. Details
2.13.2 Arigo Biolaboratories Corp. Major Business
2.13.3 Arigo Biolaboratories Corp. PSMA Antibody Product and Services
2.13.4 Arigo Biolaboratories Corp. PSMA Antibody Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Arigo Biolaboratories Corp. Recent Developments/Updates
3 Competitive Environment: PSMA Antibody by Manufacturer
3.1 Global PSMA Antibody Sales Quantity by Manufacturer (2020-2025)
3.2 Global PSMA Antibody Revenue by Manufacturer (2020-2025)
3.3 Global PSMA Antibody Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of PSMA Antibody by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 PSMA Antibody Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 PSMA Antibody Manufacturer 麻豆原创 Share in 2024
3.5 PSMA Antibody 麻豆原创: Overall Company Footprint Analysis
3.5.1 PSMA Antibody 麻豆原创: Region Footprint
3.5.2 PSMA Antibody 麻豆原创: Company Product Type Footprint
3.5.3 PSMA Antibody 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global PSMA Antibody 麻豆原创 Size by Region
4.1.1 Global PSMA Antibody Sales Quantity by Region (2020-2031)
4.1.2 Global PSMA Antibody Consumption Value by Region (2020-2031)
4.1.3 Global PSMA Antibody Average Price by Region (2020-2031)
4.2 North America PSMA Antibody Consumption Value (2020-2031)
4.3 Europe PSMA Antibody Consumption Value (2020-2031)
4.4 Asia-Pacific PSMA Antibody Consumption Value (2020-2031)
4.5 South America PSMA Antibody Consumption Value (2020-2031)
4.6 Middle East & Africa PSMA Antibody Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global PSMA Antibody Sales Quantity by Type (2020-2031)
5.2 Global PSMA Antibody Consumption Value by Type (2020-2031)
5.3 Global PSMA Antibody Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global PSMA Antibody Sales Quantity by Application (2020-2031)
6.2 Global PSMA Antibody Consumption Value by Application (2020-2031)
6.3 Global PSMA Antibody Average Price by Application (2020-2031)
7 North America
7.1 North America PSMA Antibody Sales Quantity by Type (2020-2031)
7.2 North America PSMA Antibody Sales Quantity by Application (2020-2031)
7.3 North America PSMA Antibody 麻豆原创 Size by Country
7.3.1 North America PSMA Antibody Sales Quantity by Country (2020-2031)
7.3.2 North America PSMA Antibody Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe PSMA Antibody Sales Quantity by Type (2020-2031)
8.2 Europe PSMA Antibody Sales Quantity by Application (2020-2031)
8.3 Europe PSMA Antibody 麻豆原创 Size by Country
8.3.1 Europe PSMA Antibody Sales Quantity by Country (2020-2031)
8.3.2 Europe PSMA Antibody Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific PSMA Antibody Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific PSMA Antibody Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific PSMA Antibody 麻豆原创 Size by Region
9.3.1 Asia-Pacific PSMA Antibody Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific PSMA Antibody Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America PSMA Antibody Sales Quantity by Type (2020-2031)
10.2 South America PSMA Antibody Sales Quantity by Application (2020-2031)
10.3 South America PSMA Antibody 麻豆原创 Size by Country
10.3.1 South America PSMA Antibody Sales Quantity by Country (2020-2031)
10.3.2 South America PSMA Antibody Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa PSMA Antibody Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa PSMA Antibody Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa PSMA Antibody 麻豆原创 Size by Country
11.3.1 Middle East & Africa PSMA Antibody Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa PSMA Antibody Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 PSMA Antibody 麻豆原创 Drivers
12.2 PSMA Antibody 麻豆原创 Restraints
12.3 PSMA Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of PSMA Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of PSMA Antibody
13.3 PSMA Antibody Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PSMA Antibody Typical Distributors
14.3 PSMA Antibody Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Sino Biological, Inc.
ACROBiosystems
Bio-Techne
Abcam
Elabscience Biotechnology Inc.
LifeSpan BioSciences, Inc
ProSci Incorporated
Boster Biological Technology
Abbexa
Assay Genie
Innovative Research
G&P Biosciences
Arigo Biolaboratories Corp.
听
听
*If Applicable.
